Advanced company searchLink opens in new window

DERMAVANT HOLDINGS LIMITED

Company number 10317657

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Feb 2026 AA Full accounts made up to 31 December 2024
25 Sep 2025 AP01 Appointment of Nicola Barr as a director on 1 September 2025
10 Sep 2025 AP01 Appointment of Anne Bitzer as a director on 1 September 2025
03 Sep 2025 AA01 Previous accounting period shortened from 31 March 2025 to 31 December 2024
19 Aug 2025 CS01 Confirmation statement made on 8 August 2025 with no updates
19 Aug 2025 TM01 Termination of appointment of Isabel Vandenberk as a director on 31 July 2025
30 Jul 2025 TM01 Termination of appointment of Sandy Lindsey as a director on 30 May 2025
24 Mar 2025 AA Full accounts made up to 31 March 2024
27 Nov 2024 RP04AP01 Second filing for the appointment of Mr Josef Ralph Laskowski as a director
13 Nov 2024 AP01 Appointment of Sandy Lindsey as a director on 28 October 2024
12 Nov 2024 AP01 Appointment of Isabel Vandenberk as a director on 28 October 2024
12 Nov 2024 AP01 Appointment of Michael Whale as a director on 28 October 2024
08 Nov 2024 AD01 Registered office address changed from 7th Floor 50 Broadway London SW1H 0DB United Kingdom to Organon Pharma (Uk) Limited Shotton Lane Cramlington NE23 3JU on 8 November 2024
07 Nov 2024 TM01 Termination of appointment of Lee Francis Moore as a director on 28 October 2024
07 Nov 2024 TM01 Termination of appointment of Caterina Musgrave Juer as a director on 28 October 2024
07 Nov 2024 TM02 Termination of appointment of Vistra Cosec Limited as a secretary on 28 October 2024
07 Nov 2024 AP03 Appointment of Mr John Albert Parsons as a secretary on 28 October 2024
07 Nov 2024 AP01 Appointment of Mr Joseph Ralph Laskowski as a director on 28 October 2024
  • ANNOTATION Clarification a second filed AP01 was registered on 27/11/2024.
07 Nov 2024 PSC02 Notification of Organon & Co. as a person with significant control on 28 October 2024
07 Nov 2024 PSC07 Cessation of Roivant Sciences Ltd. as a person with significant control on 28 October 2024
31 Oct 2024 MR04 Satisfaction of charge 103176570005 in full
25 Oct 2024 MR04 Satisfaction of charge 103176570001 in full
25 Oct 2024 MR04 Satisfaction of charge 103176570002 in full
25 Oct 2024 MR04 Satisfaction of charge 103176570003 in full
25 Oct 2024 MR04 Satisfaction of charge 103176570004 in full